Notice: This company has been marked as potentially delisted and may not be actively trading. Genesis Healthcare (GEN) Stock Forecast & Price Target Add Compare Share Share Analyst Forecasts Stock AnalysisAnalyst ForecastsCompetitorsDividendEarningsHeadlinesInsider TradesOptions ChainOwnershipTrends Get the Latest News and Ratings for GEN and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Genesis Healthcare and its competitors. Enter your email to sign up for newsletter Sign Up GEN Analyst Ratings Over TimeTypeCurrent Forecast12/17/23 to 12/16/241 Month Ago11/17/23 to 11/16/243 Months Ago9/18/23 to 9/17/241 Year Ago12/17/22 to 12/17/23Strong Buy0 Strong Buy rating(s)0 Strong Buy rating(s)0 Strong Buy rating(s)0 Strong Buy rating(s)Buy3 Buy rating(s)3 Buy rating(s)2 Buy rating(s)4 Buy rating(s)Hold3 Hold rating(s)3 Hold rating(s)3 Hold rating(s)1 Hold rating(s)Sell0 Sell rating(s)0 Sell rating(s)0 Sell rating(s)0 Sell rating(s)Consensus Price Target$31.33$29.33$27.20$24.60Forecasted Upside4.93% Upside-0.83% Downside2.80% Upside6.13% UpsideConsensus RatingModerate BuyModerate BuyHoldModerate Buy URGENT: This Altcoin Opportunity Won’t Wait – Act Now (Ad)It’s here. This is the moment we’ve been waiting for. The next 3-6 months in crypto will be absolutely life-changing for those who are prepared. Why? Because altcoin prices are about to explode.>> Register for the Workshop Now GEN Analyst Recommendations By MonthAnalyst Ratings Chart DescriptionThe chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.Skip Chart & View Analyst Rating History GEN Price Targets by MonthAverage Share Price and Price Target by Month Chart DescriptionThe chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table Genesis Healthcare Stock vs. The CompetitionTypeGenesis HealthcareBusiness Services CompaniesS&P 500Consensus Rating Score 2.50 2.68 2.51Consensus RatingModerate BuyModerate BuyModerate BuyPredicted Upside4.93% Upside233.39% Upside10.36% UpsideNews Sentiment RatingNeutral NewsSee Recent GEN NewsPositive NewsPositive News Recent Analyst Forecasts and Stock Ratings All Ratings Strong Buy Buy Hold Sell Rating Show All Upside > 100% Upside 50% - 100% Upside 20% - 50% Upside 10% - 20% Upside 0% - 10% Downside 0% - 10% Downside 10% - 20% Downside 20% - 50% Downside 50% - 100% Downside > 100% Upside/Downside All Actions Upgrades Downgrades Initiates Coverage Raises Target Lowers Target Reiterates Rating Action Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Years 5 Years Time Frame Start Date End Date Most Recent from Each Brokerage All Show Export to Excel DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails12/11/2024Royal Bank of Canada4 of 5 stars Reiterated RatingSector Perform ➝ Sector Perform$29.00 ➝ $29.00-2.75%12/4/2024UBS Group4 of 5 stars Initiated CoverageBuy$36.00+16.73%10/31/2024Wells Fargo & Company3 of 5 stars Boost TargetOverweight ➝ Overweight$35.00 ➝ $37.00+27.10%10/31/2024BarclaysSubscribe to MarketBeat All Access for the recommendation accuracy rating Boost TargetEqual Weight ➝ Equal Weight$28.00 ➝ $30.00+11.48%6/7/2024Morgan StanleySubscribe to MarketBeat All Access for the recommendation accuracy rating DowngradeOverweight ➝ Equal Weight$28.00 ➝ $27.00+6.13%5/28/2024ArgusSubscribe to MarketBeat All Access for the recommendation accuracy rating Boost TargetBuy ➝ Buy$26.00 ➝ $29.00+16.51%11/16/2023Bank of AmericaSubscribe to MarketBeat All Access for the recommendation accuracy rating Initiated CoverageBuy$25.00+26.52%5/19/2023Evercore ISISubscribe to MarketBeat All Access for the recommendation accuracy rating Initiated CoverageOutperform$27.00+67.49%Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Monday at 01:46 PM ET. GEN Forecast - Frequently Asked Questions What is Genesis Healthcare's forecast for 2025? According to the research reports of 6 Wall Street equities research analysts, the average twelve-month stock price forecast for Genesis Healthcare is $31.33, with a high forecast of $37.00 and a low forecast of $27.00. Should I buy or sell Genesis Healthcare stock right now? 6 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Genesis Healthcare in the last year. There are currently 3 hold ratings and 3 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "moderate buy" GEN shares. Does Genesis Healthcare's stock price have much upside? According to analysts, Genesis Healthcare's stock has a predicted upside of 4.93% based on their 12-month stock forecasts. What analysts cover Genesis Healthcare? Genesis Healthcare has been rated by research analysts at Barclays, Royal Bank of Canada, UBS Group, and Wells Fargo & Company in the past 90 days. Do Wall Street analysts like Genesis Healthcare more than its competitors? Analysts like Genesis Healthcare less than other "business services" companies. The consensus rating score for Genesis Healthcare is 2.50 while the average consensus rating score for "business services" companies is 2.68. Learn more on how GEN compares to other companies. Stock Forecasts and Research Tools Related Companies SNPS Stock Forecast TEAM Stock Forecast ADSK Stock Forecast NTES Stock Forecast SNOW Stock Forecast SQ Stock Forecast DDOG Stock Forecast EA Stock Forecast VEEV Stock Forecast NET Stock Forecast Today's Ratings U.S. Ratings U.K. Ratings Canadian Ratings All Upgrades All Downgrades All Initiations All Price Target Changes Top Rated Stocks Top Rated Stocks Top Rated Dividend Stocks Top Rated Small-Cap Stocks Top Rated Tech Stocks Most Upgraded Stocks Most Downgraded Stocks Lowest Rated Stocks More Ratings Tools Stock Ratings by Issuer Top-Rated Analysts Top-Rated Brokerages Stock Ratings Screener Free Ratings Newsletter URGENT: This Altcoin Opportunity Won’t Wait – Act Now (Ad)It’s here. This is the moment we’ve been waiting for. The next 3-6 months in crypto will be absolutely life-changing for those who are prepared. Why? Because altcoin prices are about to explode.>> Register for the Workshop Now This page (NYSE:GEN) was last updated on 12/16/2024 by MarketBeat.com Staff From Our PartnersMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | SponsoredAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | SponsoredBuffett's Oil Bet + This 22% Dividend PlayWarren Buffett has been quietly amassing a massive position in oil stocks. But while Buffett's picks (Occid...Investors Alley | SponsoredWall Street Icon: “If you wait on this, it will already be too late”...Investing legend Louis Navellier warned us about the stock market crash of 1987... the 2000 dot-com crash… Enr...InvestorPlace | Sponsored"This looks and feels like 2000," says investing legendOur senior analyst Dan Ferris says a new surprise crisis could begin at any moment... and this time, he says i...Stansberry Research | SponsoredNvidia’s Bold Move: Tackling Tech’s $1 Trillion CrisisTaiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as ...Weiss Ratings | Sponsored⭕ [URGENT] Buy Alert just triggeredMy absolute favorite stock just hit a critical "buy now" trigger price.Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Genesis Healthcare, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Genesis Healthcare With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free GEN Stock Alerts